Advanced search×

Olmesartan, microalbuminuria, and type 2 diabetes.

John S Yudkin and Richard Lehman

N Engl J Med 364(23):2260; author reply 2262-3 (2011) PMID 21651401

DOI: 10.1056/NEJMc1104826#SA1
Version: za2963e q8za7 q8zb7 q8zc6 q8zd4 q8ze4 q8zf4 q8zg2
Buy PDF

Similar articles you may find interesting…

  1. A Randomized Controlled Trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the tre...
    A M Agius, N S Jones, and R Muscat

    Rhinology 51(2):143-53 (2013) PMID 23671895

    Patients often present to otolaryngologists with chronic facial pain, presumed to be of sinus origin despite normal nasal endoscopy and sinus CT. This pain has increasingly been recognized as being of neurological origin with one of the commonest underlying causes being mid-facial se...
    Buy PDF
  2. Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetes.
    Sheila A Doggrell

    Expert Opin Pharmacother (2013) PMID 23641928

    There is a debate as to whether percutaneous coronary intervention (PCI) with drug-eluting stents or coronary artery bypass surgery (CABG) is the best procedure for subjects with type 2 diabetes and coronary artery disease requiring revascularization. There is some evidence that by f...
    Buy PDF
  3. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study.
    Haiyan Chu, Meilin Wang, and Zhengdong Zhang

    Diabetes Metab Res Rev (2013) PMID 23653335

    Overall, we found that individuals with the -11426G allele had a 0.15-fold significantly increased T2DM risk (additive model: 1.15, 1.04-1.27, 0.222). In the stratified analyses, we found that the -11426A > G, -11391G > A, and -11377 C > G polymorphisms could increase T2DM risk in Europe...
    Buy PDF